FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 50% Injection
Status: Currently in Shortage
»Date first posted: 04/27/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc./IMS (New 04/28/2017)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
DEXTROSE INJECTION, USP, 50%, [500 mg / mL](NDC 76329-3301-1) IMS is releasing product; however, the demand is greater than the supply at this time. Demand increase for the drug

Hospira, Inc. (Revised 06/16/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50% (0.5 g/mL); 25 g/50 mL LifeShield™ Abboject™ Glass Syringe (18 G x 1 1/2“) (NDC 00409-4902-34) Next Delivery: June 2017; Estimated Recovery: Late August 2017 Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
50% (0.5 g/mL); 25 g/50 mL Single Dose Glass Fliptop Vial (NDC 00409-6648-02) Next Delivery: Late June 2017; Estimated Recovery: 1Q 2018 Shortage per Manufacturer: Manufacturing Delay Other
50% (0.5 g/mL); 25 g/50 mL Ansyr™ II Plastic Syringe (NDC 00409-7517-16) Next Delivery: July 2017; Estimated Recovery: October 2017 Please check with your wholesaler for available inventory Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English